Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort

Immunology

Volumn 133, Issue 3, 2011, Pages 379-385

  Campbell, Elaine C ^a   Fettke, Franziska ^a   Bhat, Smita ^b   Morley, Kenneth D ^b   Powis, Simon J ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Antigen presentation; Arthritis rheumatoidarthritis; MHC HLA; Rheumatology Rheumatic disease

Indexed keywords

AMINOPEPTIDASE; DIMER; GENE PRODUCT; GLUCOSE REGULATED PROTEIN 78; HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HC10; PROTEIN ERAP1; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; ERAP1 GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HEAVY CHAIN; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTIVE ARTHRITIS; RNA SPLICING; XBP1 GENE;

AMINOPEPTIDASES; COHORT STUDIES; DENDRITIC CELLS; DIMERIZATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; PROTEIN FOLDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPONDYLITIS, ANKYLOSING;

EID: 79957819259     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03453.x     Document Type: Article

References (25)

1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973; 1:904-7.
2. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288:704-6.
3. Taurog JD, Dorris ML, Satumtira N, Tran TM, Sharma R, Dressel R, van den Brandt J, Reichardt HM. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum 2009; 60:1977-84.
4. Colbert RA, DeLay ML, Layh-Schmitt G, Sowders DP. HLA-B27 misfolding and spondyloarthropathies. Adv Exp Med Biol 2009; 649:217-34.
5. Powis SJ, Santos SG, Antoniou AN. Biochemical features of HLA-B27 and antigen processing. Adv Exp Med Biol 2009; 649:210-6.
6. Antoniou AN, Ford S, Taurog JD, Butcher GW, Powis SJ. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J Biol Chem 2004; 279:8895-902.
7. Mear JP, Schreiber KL, Munz C, Zhu X, Stevanovic S, Rammensee HG, Rowland-Jones SL, Colbert RA. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999; 163:6665-70.
8. Turner MJ, Sowders DP, DeLay ML et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175:2438-48.
9. Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999; 162:5045-8.
10. Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003; 33:748-59.
11. Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, Bowness P. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002; 46:2972-82.
12. Kollnberger S, Bird LA, Roddis M et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173:1699-710.
13. Tsai WC, Chen CJ, Yen JH, Ou TT, Tsai JJ, Liu CS, Liu HW. Free HLA class I heavy chain-carrying monocytes - a potential role in the pathogenesis of spondyloarthropathies. J Rheumatol 2002; 29:966-72.
14. Santos SG, Lynch S, Campbell EC, Antoniou AN, Powis SJ. Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cells. Arthritis Res Ther 2008; 10:R100.
15. Burton PR, Clayton DG, Cardon LR et al. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39:1329-37.
16. + T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum 2007; 56:1478-89.
17. Lynch S, Santos SG, Campbell EC, Nimmo AM, Botting C, Prescott A, Antoniou AN, Powis SJ. Novel MHC class I structures on exosomes. J Immunol 2009; 183:1884-91.
18. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60:2633-43.
19. Iwakoshi NN, Pypaert M, Glimcher LH. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J Exp Med 2007; 204:2267-75.
20. Harvey D, Pointon JJ, Evans DM et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009; 18:4204-12.
21. Fussell H, Nesbeth D, Lenart I et al. Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association. Arthritis Rheum 2008; 58:3419-24.
22. Turner MJ, Delay ML, Bai S, Klenk E, Colbert RA. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum 2007; 56:215-23.
23. Yan J, Parekh VV, Mendez-Fernandez Y et al. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 2006; 203:647-59.
24. York IA, Brehm MA, Zendzian S, Towne CF, Rock KL. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci U S A 2006; 103:9202-7.
25. Fruci D, Ferracuti S, Limongi MZ et al. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol 2006; 176:4869-79.